CORRECTION article

Front. Med., 15 December 2022

Sec. Pulmonary Medicine

Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.1116599

Corrigendum: Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension

  • Department of Cardiology, Xiangya Hospital, Central South University, Changsha, China

In the published article, there was an error in the Funding statement “This study was supported by the National Natural Science Foundation of China (Nos. 8187011311, 81873416, and 8210012237) and the Key Research and Development Program of Hunan Province (2020SK2065).” The fund numbers (8187011311, 8210012237) were the initial acceptance numbers, not the final grant numbers. The correct Funding statement appears below.

Statements

Funding

This study was supported by the National Natural Science Foundation of China (Nos. 82070055, 81873416, and 82100071) and the Key Research and Development Program of Hunan Province (2020SK2065).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

bioinformatic analysis, TXNRD1, pulmonary hypertension, biomarker, RRA, GEO

Citation

Lin W, Tang Y, Zhang M, Liang B, Wang M, Zha L and Yu Z (2022) Corrigendum: Integrated bioinformatic analysis reveals TXNRD1 as a novel biomarker and potential therapeutic target in idiopathic pulmonary arterial hypertension. Front. Med. 9:1116599. doi: 10.3389/fmed.2022.1116599

Received

05 December 2022

Accepted

06 December 2022

Published

15 December 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

9 - 2022

Updates

Copyright

*Correspondence: Zaixin Yu ✉ Lihuang Zha ✉

This article was submitted to Pulmonary Medicine, a section of the journal Frontiers in Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics